Adrian Bubie

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J Falcon, Patrick Evans, Josephine Feliciano, Christine L Hann, David S Ettinger, Kellie N Smit, Valsamo Anagnostou, Patrick M Forde, Julie R Brahmer, Benjamin Levy, Alexander E Drilon, Vincent K Lam
Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC. Cancer research communications 4 (3) (2024)
Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J Falcon, Patrick Evans, Josephine Feliciano, Christine L Hann, David S Ettinger, Kellie N Smit, Valsamo Anagnostou, Patrick M Forde, Julie R Brahmer, Benjamin Levy, Alexander E Drilon, Vincent K Lam
Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC. Cancer research communications 4 (3) (2024)
Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J Falcon, Patrick Evans, Josephine Feliciano, Christine L Hann, David S Ettinger, Kellie N Smit, Valsamo Anagnostou, Patrick M Forde, Julie R Brahmer, Benjamin Levy, Alexander E Drilon, Vincent K Lam
Impact of tumor-intrinsic molecular features on survival and acquired tyrosine kinase inhibitor resistance in ALK-positive NSCLC. Cancer research communications (2024)
Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J Falcon, Patrick Evans, Josephine Feliciano, Christine L Hann, David S Ettinger, Kellie N Smit, Valsamo Anagnostou, Patrick M Forde, Julie R Brahmer, Benjamin Levy, Alexander E Drilon, Vincent K Lam
Impact of tumor-intrinsic molecular features on survival and acquired tyrosine kinase inhibitor resistance in ALK-positive NSCLC. Cancer research communications (2024)
Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J Falcon, Patrick Evans, Josephine Feliciano, Christine L Hann, David S Ettinger, Kellie N Smit, Valsamo Anagnostou, Patrick M Forde, Julie R Brahmer, Benjamin Levy, Alexander E Drilon, Vincent K Lam
Impact of tumor-intrinsic molecular features on survival and acquired tyrosine kinase inhibitor resistance in ALK-positive NSCLC. Cancer research communications (2024)
Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J Falcon, Patrick Evans, Josephine Feliciano, Christine L Hann, David S Ettinger, Kellie N Smit, Valsamo Anagnostou, Patrick M Forde, Julie R Brahmer, Benjamin Levy, Alexander E Drilon, Vincent K Lam
Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC. Cancer research communications 4 (3) (2024)